July 2026—OptraScan launched BactoSia, an AI-assisted tuberculosis treatment monitoring and follow-up solution designed to assist with sputum smear microscopy. BactoSia combines high-resolution brightfield whole-slide imaging with AI-based algorithms to detect and quantify acid-fast bacilli on Ziehl-Neelsen-stained sputum samples. The solution performs scanning, indexing, and AI-driven analysis simultaneously and is designed to deliver slide-to-report results in minutes, generating standardized bacillary load grading (scanty, 1+, 2+, 3+) aligned with internationally recognized TB reporting. Images and reports are managed digitally within OptraScan’s ImagePath software system.
BactoSia is suited for public health laboratories, mid- to high-volume TB labs, mobile units, nongovernmental organizations, and telepathology networks.
OptraScan, 408-524-5300